Abstract
The Ras oncogene transforms cultured murine fibroblasts into malignant, focus-forming cells, whose lack of contact inhibition is evidenced by high saturation densities. In order to investigate the reversibility of Ras transformation, as well as the kinetics of Ras-induced changes, cell lines that conditionally express oncogenic Ras were constructed. Both focus formation and increased saturation density were inducible and fully reversible. In exponentially growing cells, oncogenic Ras-expression had no effect on proliferation rates, Erk phosphorylation, or the level of cyclin D1, and Ras-induction did not confer serum-independent growth. As expected, growth to high density in uninduced cells led to quiescence with a low level of cyclin D1 and no active Erk; in this setting, Ras induction prevented full downregulation of cyclin D1 and inactivation of Erk. Our results show that Ras expression to a level sufficient for transformation leads to relatively subtle effects on known downstream targets, and that the focus formation and increased saturation density growth induced by Ras is not a result of growth factor independence.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597
Balmain A, Ramsden M, Bowden GT, Smith J . 1984 Nature 307: 658–660
Brown M, Figge J, Hansen U, Wright C, Jeang K-T, Khoury G, Livingston DM, Roberts TM . 1987 Cell 49: 603–612
Chin L, Tam A, Pomerantz J, Wong M, Holash J, Bardeesy N, Shen Q, O'Hagan R, Pantginis J, Zhou H, Horner JW, II, Cordon-Cardo C, Yancopoulos GD, DePinho RA . 1999 Nature 400: 468–472
Chung HH, Kim R, Kim SH . 1992 Biochimica et Biophysica Acta 1129: 278–286
Diehl JA, Cheng M, Roussel MF, Sherr CJ . 1998 Genes Dev. 12: 3499–3511
Donze O, Jagus R, Koromilas AE, Hershey JW, Sonenberg N . 1995 EMBO J. 14: 3828–3834
Durkin JP, Whitfield JF . 1986 Mol. Cell. Biol. 6: 1386–1392
Ellis RW, DeFeo D, Maryak JM, Young H, Shih TY, Chang EH, Lowy DR, Scolnick EM . 1980 J. Virol. 36: 408–420
Fan J, Bertino JR . 1997 Oncogene 14: 2595–2607
Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL, Conti CJ . 1994 Oncogene 9: 3627–3633
Gille H, Downward J . 1999 J. Biol. Chem. 274: 22033–22040
Gjoerup O, Lukas J, Bartek J, Willumsen B . 1998 J. Biol. Chem. 273: 18812–18818
Gossen M, Bujard H . 1992 Proc. Natl. Acad. Sci. USA 89: 5547–5551
Hall CV, Jacob PE, Ringold GM, Lee F . 1983 J. Mol. Appl. Genet. 2: 101–109
Hartman SC, Mulligan RC . 1988 Proc. Natl. Acad. Sci. USA 85: 8047–8051
Harvey JJ, East J . 1971 International Review of Experiment Pathology Vol. 10: Academic Press pp 265–360
Hinds PW, Dowdy SF, Eaton EN, Arnold A, Weinberg RA . 1994 Proc. Natl. Acad. Sci. USA 91: 709–713
Hitomi M, Stacey DW . 1999 Mol. Cell. Biol. 19: 4623–4632
Holley RW . 1975 Nature 258: 487–490
Hu MC-T, Davidson N . 1987 Cell 48: 555–566
Jacobsen KD, Willumsen BM . 1995 J. Mol. Biol. 252: 289–295
Kamijo T, Zindy F, Roussel MF, Quelle DE, Downing JR, Ashmun RA, Grosveld G, Sherr CJ . 1997 Cell 91: 649–659
Kaplan PL, Anderson M, Ozanne B . 1982 Proc. Natl. Acad. Sci. USA 79: 485–489
Kumar R, Sukumar S, Barbacid M . 1990 Science 248: 1101–1104
Lavoie JN, L'Allemain G, Brunet A, Muller R, Pouyssegur J . 1996 J. Biol. Chem. 271: 20608–20616
Leevers SJ, Marshall CJ . 1992 EMBO J. 11: 569–574
Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR . 1997 Nature 387: 422–426
Liu JJ, Chao JR, Jiang MC, Ng SY, Yen JJ, Yang-Yen HF . 1995 Mol. Cell. Biol. 15: 3654–3663
Lowy DR, Willumsen BM . 1993 Ann. Rev. Biochem. 62: 851–891
Mittnacht S, Paterson H, Olson MF, Marshall CJ . 1997 Cur. Biol. 7: 219–221
Mulcahy LS, Smith MR, Stacey DW . 1985 Nature 313: 241–243
Pardee AB, Dubrow R, Hamlin JL, Kleitzen RE . 1978 Annu. Rev. Biochem. 47: 717–750
Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA, Ewen ME . 1997 Nature 386: 177–181
Pironin M, Clement G, Benzakour O, Barritault D, Lawrence D, Vigier P . 1992 Int. J. Cancer 51: 980–988
Quelle DE, Ashmun RA, Hannon GJ, Rehberger PA, Trono D, Richter KH, Walker C, Beach D, Sherr CJ, Serrano M . 1995 Oncogene 11: 635–645
Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ . 1993 Genes Dev. 7: 1559–1571
Resnitzky D, Gossen M, Bujard H, Reed SI . 1994 Mol. Cell. Biol. 14: 1669–1679
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J . 1994 Nature 370: 527–532
Samuels ML, Weber MJ, Bishop JM, McMahon M . 1993 Mol. Cell. Biol. 13: 6241–6252
Schönthal A, Herrlich P, Rahmsdorf HJ, Ponta H . 1988 Cell 54: 325–334
Serrano M, Lee HW, Chin L, Cordon-Cardo C, Beach D, DePinho RA . 1996 Cell 85: 27–37
Shih TY, Stokes PE, Smythers GW, Dhar R, Oroszlan S . 1982 J. Biol. Chem. 257: 11767–11773
Simons A, Tils D, Wilcken-Bergmann BV, Müller-Hill B . 1984 Proc. Natl. Acad. Sci. USA 81: 1624–1628
Simons PJ, Durmashkin RR, Turano A, Phillips DEH, Chesterman FC . 1967 Nature 214: 897–898
Sinn E, Muller W, Pattengale P, Tepler I, Wallace R, Leder P . 1987 Cell 49: 465–475
Ulsh L, Shih TY . 1984 Mol. Cell. Biol. 4: 1647–1652
Villalonga P, Rius E, Bachs O, Agell N . 2000 Oncogene 19: 690–699
Weinberg RA . 1995 Cell 81: 323–330
Willumsen BM . 1995 Methods Enzymol: Lipid modifications of proteins Vol. 250: Casey PJ and Buss JE. (eds) Academic Press: Orlando, FL pp 269–284
Willumsen BM, Vass WC, Velu TJ, Papageorge AG, Schiller J, Lowy DR . 1991 Mol. Cell. Biol. 11: 6026–6033
Winston JT, Coats SR, Wang YZ, Pledger WJ . 1996 Oncogene 12: 127–134
Won KA, Xiong Y, Beach D, Gilman MZ . 1992 Proc. Natl. Acad. Sci. USA 89: 9910–9914
Zavada J, Macpherson I . 1970 Nature 225: 24–26
Zhan X, Goldfarb M . 1986 Mol. Cell. Biol. 6: 3541–3544
Acknowledgements
The excellent technical assistance of Marianne Knudsen and Rikke Ingvorsen is gratefully acknowledged. We thank Douglas Lowy for critical reading of an early version of the manuscript. This work was funded by grants 97 100 13 from the Danish Cancer Society and 9600821 from the Danish Medical Research council to BM Willumsen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jacobsen, K., Groth, A. & Willumsen, B. Ras-inducible immortalized fibroblasts: focus formation without cell cycle deregulation. Oncogene 21, 3058–3067 (2002). https://doi.org/10.1038/sj.onc.1205423
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205423
Keywords
This article is cited by
-
ISGylation governs the oncogenic function of Ki-Ras in breast cancer
Oncogene (2014)
-
The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique
Journal of Biosciences (2013)
-
Identification of a c-Jun N-terminal kinase-2-dependent signal amplification cascade that regulates c-Myc levels in ras transformation
Oncogene (2012)
-
Polyploid cells rewire DNA damage response networks to overcome replication stress-induced barriers for tumour progression
Nature Communications (2012)
-
The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis
Skeletal Muscle (2011)